Total Payments
$10,167
2024 Payments
$783.27
Companies
34
Transactions
292
Medicare Patients
852
Medicare Billing
$101,336
Payment Breakdown by Category
Food & Beverage$9,877 (97.1%)
Gifts$259.97 (2.6%)
Education$30.28 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,877 | 283 | 97.1% |
| Gift | $259.97 | 4 | 2.6% |
| Education | $30.28 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,076 | 106 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $678.62 | 6 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $564.42 | 24 | $0 (2023) |
| Allergan Inc. | $540.26 | 48 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $429.73 | 4 | $0 (2023) |
| Ethicon US, LLC | $381.26 | 6 | $0 (2020) |
| Braintree Laboratories, Inc. | $375.89 | 11 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $326.43 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $260.73 | 6 | $0 (2023) |
| Novo Nordisk Inc | $238.49 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $783.27 | 33 | ABBVIE INC. ($334.08) |
| 2023 | $1,505 | 42 | ABBVIE INC. ($393.86) |
| 2022 | $1,129 | 27 | Janssen Scientific Affairs, LLC ($245.94) |
| 2021 | $941.89 | 21 | AbbVie Inc. ($384.73) |
| 2020 | $438.17 | 23 | AbbVie Inc. ($218.70) |
| 2019 | $1,936 | 35 | AbbVie, Inc. ($835.70) |
| 2018 | $2,090 | 57 | AbbVie, Inc. ($1,140) |
| 2017 | $1,344 | 54 | AbbVie, Inc. ($633.16) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Gift | Cash or cash equivalent | $81.81 | General |
| Category: GI COLON PREP | ||||||
| 10/30/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: GI COLON PREP | ||||||
| 09/25/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: VIROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: VIROLOGY | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Obesity | ||||||
| 09/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: VIROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.41 | General |
| Category: Neuroscience | ||||||
| 06/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: VIROLOGY | ||||||
| 06/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: VIROLOGY | ||||||
| 05/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: VIROLOGY | ||||||
| 04/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: VIROLOGY | ||||||
| 04/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 263 | 289 | $81,050 | $29,994 |
| 2022 | 6 | 155 | 176 | $48,675 | $19,528 |
| 2021 | 6 | 202 | 226 | $55,575 | $25,169 |
| 2020 | 8 | 232 | 247 | $70,475 | $26,645 |
Total Patients
852
Total Services
938
Medicare Billing
$101,336
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $11,800 | $6,389 | 54.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 34 | 34 | $20,400 | $5,976 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 58 | $8,700 | $5,223 | 60.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $14,400 | $3,076 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 42 | $4,200 | $2,749 | 65.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $5,950 | $2,431 | 40.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 14 | $8,400 | $2,292 | 27.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,200 | $1,858 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 66 | $9,950 | $5,872 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $8,800 | $5,284 | 60.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 19 | 19 | $11,400 | $3,447 | 30.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 24 | 25 | $10,000 | $2,070 | 20.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $6,600 | $2,055 | 31.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,925 | $800.55 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 81 | $12,200 | $7,701 | 63.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $10,200 | $6,650 | 65.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 27 | 27 | $16,200 | $5,572 | 34.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 28 | 30 | $12,000 | $2,600 | 21.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $2,975 | $1,413 | 47.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 20 | $2,000 | $1,233 | 61.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 52 | 52 | $10,400 | $6,319 | 60.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 28 | 28 | $16,800 | $5,960 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 61 | $9,150 | $4,616 | 50.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 34 | 34 | $13,600 | $2,817 | 20.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $4,025 | $1,871 | 46.5% |
About Dr. Emmanuel Mompi, MD
Dr. Emmanuel Mompi, MD is a Gastroenterology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124099742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emmanuel Mompi, MD has received a total of $10,167 in payments from pharmaceutical and medical device companies, with $783.27 received in 2024. These payments were reported across 292 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,877).
As a Medicare-enrolled provider, Mompi has provided services to 852 Medicare beneficiaries, totaling 938 services with total Medicare billing of $101,336. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Tampa, FL
- Active Since 01/31/2006
- Last Updated 03/07/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124099742
Products in Payments
- STELARA (Biological) $818.57
- Mavyret (Drug) $670.98
- Humira (Biological) $536.03
- LINZESS (Drug) $535.49
- MAVYRET (Drug) $519.92
- OCALIVA (Drug) $429.73
- XIFAXAN (Drug) $429.03
- ZEPOSIA (Drug) $357.33
- CREON (Drug) $333.75
- Creon (Drug) $319.82
- VIBERZI (Drug) $250.59
- CERTUS 140 MICROWAVE ABLATION SYSTEM (Device) $240.19
- Wegovy (Drug) $238.49
- ZEPATIER (Drug) $210.42
- Trulance (Drug) $197.49
- DUPIXENT (Biological) $151.95
- SUPREP BOWEL PREP (Drug) $142.44
- LINX Reflux Management System (Device) $141.07
- Epclusa (Drug) $124.95
- TRULANCE (Drug) $124.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Tampa
John Jacobs, M.d, M.D
Gastroenterology — Payments: $73,013
Gastroenterology $73,013
Dr. Renee Marchioni Beery, D.o, D.O
Gastroenterology — Payments: $66,910
Gastroenterology $66,910
Dr. Shaffer Mok, M.d, M.D
Gastroenterology — Payments: $35,137
Gastroenterology $35,137
Pushpak Taunk
Gastroenterology — Payments: $25,965
Gastroenterology $25,965
Dr. John Delgado, M.d, M.D
Gastroenterology — Payments: $22,410
Gastroenterology $22,410
Dr. Roland Shepard, Md, MD
Gastroenterology — Payments: $20,204
Gastroenterology $20,204